Prospective evaluation of plasma Epstein–Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma

BACKGROUND: Plasma Epstein–Barr virus (pEBV) DNA and fluorodeoxyglucose positron emission (PET) reflect tumour burden in advanced NPC. This study hypothesised that a dual endpoint based on assessing pEBV DNA clearance and PET response could predict early drug response. METHODS: Eligible patients und...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Brigette, Hui, Edwin P, King, Ann, Leung, Sing F, Kam, Michael KM, Mo, Frankie, Li, Leung, Wang, Ki, Loong, Herbert, Wong, Ashley, Chan, Charles ML, Chan, KC Allen, Wong, SC Cesar, Lo, YM Dennis, Chan, Anthony TC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931094/
https://www.ncbi.nlm.nih.gov/pubmed/29555989
http://dx.doi.org/10.1038/s41416-018-0026-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931094/
https://www.ncbi.nlm.nih.gov/pubmed/29555989
http://dx.doi.org/10.1038/s41416-018-0026-9

Ejemplares similares